文献速递免疫规划

无黄热病毒流行区儿童与成人接种17DD黄热病疫苗后体液免疫与细胞免疫的探索性研究

Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
PubMed 文献 · Vaccine · 2021-12-27

该研究包含两个独立观察组,评估既往黄病毒体液免疫和年龄对17DD黄热病疫苗免疫的影响。对288名9月龄至4岁儿童和288名18至49岁成人检测黄病毒血清学和黄热病特异性细胞免疫。结果显示,尽管黄热病中和抗体相似,但年龄影响初次接种17DD黄热病疫苗后细胞免疫应答的持续时间。

要点

  • 成人基线黄病毒血清阳性率高于儿童(26%;87%;67% vs 6%;13%;15%)。
  • 初次接种后成人中和抗体水平高于低龄儿童(9月龄至2岁)。
  • 所有年龄亚组D30-45细胞免疫标志物升高,但仅低龄儿童D365 EMCD8进行性下降。

核心结论

  • 无论黄热病中和抗体表现如何相似,年龄影响初次接种17DD黄热病疫苗后细胞免疫应答的持续时间。

研究设计与样本

  • 研究包含两个独立观察组,评估既往黄病毒体液免疫和年龄对17DD黄热病疫苗免疫的影响。
  • 纳入288名9月龄至4岁儿童和288名18至49岁成人,均为无黄热病毒流行区居民。
  • 检测黄病毒(黄热病毒、登革病毒、寨卡病毒)血清学和黄热病特异性细胞免疫。

主要发现

  • 基线黄病毒血清阳性率在成人高于儿童(26%;87%;67% vs 6%;13%;15%)。
  • 异源黄病毒血清阳性(登革病毒、寨卡病毒)在基线不影响黄热病特异性细胞免疫应答。
  • 既往黄热病毒血清阳性者中观察到更高水平的NCD4、EMCD8、IFN-MCD8、NCD19和nCMCD19。
  • 黄热病毒血清阴性志愿者初次接种后,成人黄热病中和抗体水平高于低龄儿童(9月龄至2岁)。
  • 尽管儿童和成人D30-45血清阳性率相似,但低龄儿童(9月龄至2岁)D365血清阳性率较低(94%;95%;100% vs 87%;96%;99%)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The present investigation comprised two independent observational arms to evaluate the influence of pre-existing flavivirus humoral immunity and the age-impact on 17DD-YF vaccination immunity. Flavivirus (YFV; DENV; ZIKV) serology and YF-specific cellular immunity was evaluated in 288 children/9Mths-4Yrs and 288 adults/18-49Yrs residents of areas without YFV circulation. Data demonstrated that flavivirus seropositivity at baseline was higher in Adults as compared to Children (26%;87%;67% vs 6%;13%;15%, respectively). The heterologous flavivirus seropositivity (DENV; ZIKV) did not impact the YF-specific cellular immune response at baseline. However, higher levels of NCD4, EMCD8, IFN-MCD8, NCD19 and nCMCD19 were observed in subjects with pre-existing YFV seropositivity. Primary vaccination of YFV-seronegative volunteers led to higher levels of YF-neutralizing antibodies in Adults as compared to Younger Children (9Mths-2Yrs). Although similar seropositivity rates observed amongst Children and Adults at D30-45, lower rates were observed in Younger Children (9Mths-2Yrs) at D365 (94%;95%;100% vs 87%;96%;99%, respectively). A progressive decline in antibody levels were reported at D365, being more expressive in Children as compared to Adults. All age-subgroups exhibited at D30-45 increased levels of eEfCD4, EMCD4, IFN-MCD8 and nCMCD19 together with a decrease of eEfCD8 and CMCD8. While an increase of EMCD8 were observed in all subgroups at D30-45, a declined duration at D365 was reported only in Younger Children (9Mths-2Yrs). Biomarker signatures further support that only Younger Children (9Mths-2Yrs) presented a progressive decline of EMCD8 at D365. Together, these findings demonstrated that regardless the similarities observed in YF-neutralizing antibodies, the age impacts the duration of cellular immune response to primary 17DD-YF vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Reis LR, Costa-Rocha IAD, Campi-Azevedo AC, et al. Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus. Vaccine. 2021. PMID: 34969545. doi:10.1016/j.vaccine.2021.12.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。